Back to Agenda
Regulatory Cooperation Between the United States and Japan
Session Chair(s)
Representative Invited
FDA, United States
This session provides an update on the current regulatory affairs between FDA and PMDA. Both agencies will highlight significant regulatory collaboration in two areas, oncology and drug safety and discuss future regulatory activities in their region.
Learning Objective : Provide a regulatory update on the latest regulatory collaboration between the United States and Japan; Learn about new key areas for further regulatory collaboration between FDA and PMDA.
Have an account?